Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high-dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia.

ABSTRACT:

SUBMITTER: Ikeda K 

PROVIDER: S-EPMC11885068 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature